GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (TSX:TH) » Definitions » Other Financing

Theratechnologies (TSX:TH) Other Financing : C$-7.7 Mil (TTM As of Feb. 2025)


View and export this data going back to 1998. Start your Free Trial

What is Theratechnologies Other Financing?

Theratechnologies's Other Financing for the three months ended in Feb. 2025 was C$-0.3 Mil.

Theratechnologies's Other Financing for the trailing twelve months (TTM) ended in Feb. 2025 was C$-7.7 Mil.

Theratechnologies Other Financing Historical Data

The historical data trend for Theratechnologies's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Other Financing Chart

Theratechnologies Annual Data
Trend Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.71 -9.43 -5.32 -3.40 -7.55

Theratechnologies Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.21 -0.71 -0.09 -6.52 -0.34

Theratechnologies Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Feb. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-7.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theratechnologies Other Financing Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Theratechnologies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (TSX:TH) » Definitions » Other Financing
Comparable Companies
TSX:EPRX TSX:FRX NEOE:CYBN TSXV:NGEN XCNQ:METX TSXV:ARCH TSX:MSCL TSX:MDNA XCNQ:GLAB TSX:ONC VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
THTX:USA TQ80:Germany
Address
2015, rue Peel, 11th Floor, Montreal, QC, CAN, H3A 1T8
Website
https://www.theratech.com
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
Executives
Dale Weil Director
Joseph Arena Director
Philippe Dubuc Senior Officer
Gérald A. Lacoste Director
Paul Lévesque Senior Officer
Andrew Molson Director
Dawn Svoronos Director
John Leasure Senior Officer
Alain Trudeau Director
Sheila Frame Director
Gary Peter Littlejohn Director
Marie-noël Colussi Senior Officer
Jovan Antunovic Senior Officer
Christian Marsolais Senior Officer
Jocelyn Lafond Senior Officer